Article

Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text
Advertising


Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates



Journal of the American Academy of Dermatology
Volume 52, n° 6
pages 997-1002 (juin 2005)
Doi : 10.1016/j.jaad.2004.12.033
DERMATOLOGIC SURGERY

Cutaneous squamous carcinoma in situ (Bowen's disease): Treatment with Mohs micrographic surgery
 

Igal Leibovitch, MD a, Shyamala C. Huilgol, MBBS, FACD b, Dinesh Selva, MBBS, FRACS, FRANZCO a, c, , Shawn Richards, MBBS, FACD d, Robert Paver, MBBS, FACD d
a From the Oculoplastic and Orbital Division, Department of Ophthalmology and Visual Sciences 
b Department of Dermatology, Royal Adelaide Hospital, University of Adelaide 
c Department of Surgery, University of Adelaide 
d Skin and Cancer Foundation Australia, Sydney 

Reprint requests: Dinesh Selva, MBBS, FRACS, FRANZCO, Oculoplastic and Orbital Division, Department of Ophthalmology and Visual Sciences, Royal Adelaide Hospital, N Terrace, Adelaide, 5000 South Australia.

Adelaide and Sydney, Australia

Abstract
Background

Bowen's disease (BD), also known as squamous intraepidermal carcinoma, is a malignant skin tumor with a potential to progress to invasive carcinoma.

Objective

We sought to report a large series of patients with BD treated with Mohs micrographic surgery (MMS).

Methods

This prospective, multicenter, case series included all patients in Australia treated with MMS for BD, who were monitored by the Skin and Cancer Foundation between 1993 and 2002.

Results

There were 270 cases; the majority (93.4%) were located in the head and neck area. In 50.7% of cases it was a recurrent tumor. In 20% the tumor was initially misdiagnosed as basal cell carcinoma or squamous cell carcinoma. No cases with perineural invasion were diagnosed. There were 6 cases of recurrence (6.3%) of 95 patients who completed a 5-year follow-up period after MMS.

Conclusion

The low 5-year recurrence rate of BD with MMS emphasizes the importance of margin-controlled excision, especially in the head and neck area where tissue preservation is essential.

The full text of this article is available in PDF format.

 Funding sources: None.
Conflicts of interest: None identified.



© 2005  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Close
Article Outline
You can move this window by clicking on the headline